ACS biomaterials science & engineeringFeb 19, 2026

Lipid nanoparticles with a new ionizable lipid help deliver OVA-mRNA to prevent melanoma in mice

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗

Updated Feb 20, 2026

Abstract

The O2-N5-OLE lipid nanoparticle (LNP) exhibited superior mRNA delivery capabilities, particularly in immune cells.

Twelve novel ionizable lipids were synthesized, incorporating specific chemical features to enhance mRNA delivery.
The O2-N5-OLE LNP was formulated with mRNA and demonstrated superior tumor suppression in a mouse melanoma model.
OVA mRNA delivered by O2-N5-OLE LNP significantly increased serum OVA-IgG and IFN-γ levels.
The vaccine activated both humoral and cellular immunity by stimulating dendritic cells and CD8T lymphocytes.
The O2-N5-OLE LNP showed excellent biocompatibility, suggesting potential for clinical application.

Simplified

Lipid nanoparticles (LNPs) have emerged as a powerful platform for mRNA vaccine delivery, with ionizable lipids playing a pivotal role in enhancing cellular uptake and endosomal escape, thereby improving therapeutic efficacy. In this study, we designed and synthesized 12 novel ionizable lipids via molecular hybridization, incorporating a hydroxyalkylamine headgroup, an ester linkage, and a-double bond tail. These lipids were then formulated into LNPs with helper lipids and eGFP or LUC mRNA. Through cell transfection and in vivo imaging experiments, the O2-N5-OLE LNP was identified with superior mRNA delivery capabilities, particularly in immune cells. Subsequently, it was employed to encapsulate the tumor model antigen ovalbumin (OVA) mRNA vaccine, and its preventive effects against mouse melanoma were evaluated. The results demonstrated that O2-N5-OLE LNP@OVA mRNA exhibits superior tumor suppression. Additionally, the OVA mRNA delivered by O2-N5-OLE LNP significantly elevated serum OVA-IgG and IFN-γ levels and activated dendritic cells and CD8T lymphocytes, indicating that the vaccine effectively activated both humoral and cellular immunity. Coupled with the excellent biocompatibility of the O2-N5-OLE LNP, these findings highlight its remarkable delivery efficacy and provide a strong experimental foundation for its potential clinical application. cis +

Full Text

Full text is available at the source.

View Full Text ↗

Lipid nanoparticles with a new ionizable lipid help deliver OVA-mRNA to prevent melanoma in mice

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief